Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database

Adv Ther. 2018 Sep;35(9):1452. doi: 10.1007/s12325-018-0767-0.

Jennifer L Beebe-Dimmer^{1

2}, Julie J Ruterbusch^{3

4}, Lauren C Bylsma^{5

6}, Christina Gillezeau^{5

6}, Jon Fryzek^{5

6}, Neil M Schultz⁷, Scott C Flanders⁷, Arie Barlev⁸, Elisabeth Heath^{3

4}, Ruben G W Quek⁸

¹ Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA. dimmerj@karmanos.org.
² Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA. dimmerj@karmanos.org.
³ Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
⁴ Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA.
⁵ EpidStat Institute, Ann Arbor, MI, USA.
⁶ EpidStat Institute, Rockville, MD, USA.
⁷ Astellas Pharma Inc., Northbrook, IL, USA.
⁸ Pfizer, Inc., San Francisco, CA, USA.

Abstract

The original article can be found online.